Nanoantibodies applications in medicine
Ars Pharmaceutica
; 63(2):189-203, 2022.
Article
in Spanish
| EMBASE | ID: covidwho-1798584
ABSTRACT
Introduction:
Nanoantibodies are composed solely of the variable region of the heavy chain and are obtained from some species of camelids and sharks. They have high binding capacity, high specificity, small size, high accessibility, and high tissue penetration, so they could potentially be used to treat, diagnose, and prevent several diseases.Method:
A bibliographic review of the medical applications of nanoantibodies was carried out. Scientific articles were examined, published in English and Spanish from 2015 to 2021 in Google Academic, Elsevier, PubMed, Clinical trials, Annual Reviews, and ScienceDirect databases. Studies that showed greater value according to language, information accuracy, and publication date were preferred. Results anddiscussion:
21 articles were selected to be evaluated and analyzed, of which 20 were preclinical studies and one clinical study. Nanoantibodies stand out as therapeutic, diagnostic, and preventive alternatives against cancer, hepatitis C, Alzheimer’s disease, Parkinson’s disease, diarrhea caused by rotavirus, and COVID-19.Conclusions:
Nanoantibodies can be very useful for the prevention, diagnosis, and treatment of different diseases;however, it is necessary to continue developing clinical and preclinical studies that support the safety and efficacy of these drugs.
Alzheimer disease; article; coronavirus disease 2019; data accuracy; diarrhea; drug safety; hepatitis C; human; language; malignant neoplasm; Medline; nonhuman; Parkinson disease; preclinical study; prevention; Rotavirus; ScienceDirect; Severe acute respiratory syndrome coronavirus 2; systematic review
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
Spanish
Journal:
Ars Pharmaceutica
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS